Theranexus (EPA:ALTHX)

BRIEF

published on 10/14/2025 at 18:35, 6 months 20 days ago

THX Pharma and Exeltis Advance Toward Commercialization of TX01

Marketing Rare Diseases Exeltis TX01 THX Pharma
PRESS RELEASE

published on 10/14/2025 at 18:30, 6 months 20 days ago

THX PHARMA (THERANEXUS) AND EXELTIS ACHIEVE KEY MILESTONE TOWARDS THE COMMERCIALIZATION OF TX01
THX Pharma (Theranexus) and Exeltis achieve key milestone towards the commercialization of TX01 for rare neurological diseases, including Gaucher and Niemann-Pick type C. A pivotal step towards regulatory submission and global launch

Commercialization Neurological Diseases Exeltis TX01 THX Pharma
BRIEF

published on 09/29/2025 at 18:35, 7 months 4 days ago

THX Pharma: a strategic evolution towards international expansion

Growth Strategy Rare Diseases THX Pharma International Marketing Drugs TX01 And Batten-1
PRESS RELEASE

published on 09/29/2025 at 18:30, 7 months 4 days ago

Theranexus Becomes THX Pharma: A Strategic Evolution Toward the Commercialization of Its Medicines for Rare Diseases
THX Pharma (formerly Theranexus) announces strategic focus on regulatory approval, early access, and global commercialization of new drug candidates for rare neurological diseases

Regulatory Approval Commercialization Rare Neurological Diseases THX Pharma Early Access
BRIEF

published on 09/25/2025 at 18:05, 7 months 8 days ago

Theranexus publishes its financial results for the first half of 2025

Financial Results Cost Reduction Theranexus Batten-1 TX01
PRESS RELEASE

published on 09/25/2025 at 18:00, 7 months 8 days ago

THERANEXUS ANNOUNCES FIRST HALF 2025 FINANCIAL RESULTS
Theranexus announces first half 2025 financial results showing a decrease in operating expenses and a net loss of €1,072 K. Focus on developing flagship asset TX01 and advancing Batten-1

Financial Results Theranexus Batten-1 Operating Expenses TX01
BRIEF

published on 07/17/2025 at 18:05, 9 months 17 days ago

Half-Yearly Review of the Theranexus Liquidity Contract

Liquidity Contract PORTZAMPARC Financial Statement Biopharmaceuticals Theranexus
BRIEF

published on 07/10/2025 at 18:05, 9 months 24 days ago

Theranexus Reveals its Cash Position as of June 30, 2025

Treasury Biopharmaceutical Innovation Theranexus Batten-1 Neurological Diseases
PRESS RELEASE

published on 07/10/2025 at 18:00, 9 months 24 days ago

THERANEXUS PUBLISHES ITS CASH POSITION AS OF 30 JUNE 2025
Theranexus, a biopharmaceutical company, reports a cash position of €2.1M as of 30 June 2025, with upcoming funds and financial visibility through Q2 2026. CEO discusses collaborations and strategic progress. H1 2025 results expected on September 25, 2025

Cash Position Biopharmaceutical Financial Publication Theranexus Rare Neurological Diseases
BRIEF

published on 05/13/2025 at 18:05, 11 months 21 days ago

Theranexus and BBDF reveal promising results for Batten-1

Theranexus Batten-1 BBDF Batten Disease Visual Acuity

Published on 05/02/2026 at 21:00, 22 hours 55 minutes ago

GECC Subsidiary Provides Update on its Lawsuit for Damages Against the Lender of the Atmosphere Project
Published on 05/02/2026 at 01:30, 1 day 18 hours ago

Uraniumx Reports Strong Financial Position Ahead of Spring Drill Program
Published on 05/02/2026 at 00:50, 1 day 19 hours ago

CoTec Announces Annual Stock Option, Restricted Share Unit And Deferred Share Unit Grants
Published on 05/02/2026 at 00:00, 1 day 19 hours ago

Redwood AI Announces Enhanced AI Models, Increasing Evaluated Chemical Reactions Following Preliminary Results from UBC Collaboration
Published on 05/02/2026 at 00:00, 1 day 19 hours ago

Onco-Innovations Expands Manufacturing Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services, Advancing Multi-Kilogram Non-GMP Synthesis to Support IND-Enabling Studies

View all ACCESSWIRE

Published on 05/03/2026 at 04:45, 15 hours 9 minutes ago

GWM Unveils World-Class Safety & Testing Facilities: Safety Built on Data, Not Hype
Published on 05/02/2026 at 15:35, 1 day 4 hours ago

Ecuador's banana sector renews labor agreement, with jobs meeting global standards
Published on 05/01/2026 at 19:23, 2 days ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/01/2026 at 18:40, 2 days 1 hour ago

Holding(s) in Company
Published on 05/01/2026 at 17:47, 2 days 2 hours ago

Key Figures 30.04.2026

View all EQS

Published on 04/30/2026 at 20:00, 2 days 23 hours ago

AMA Corp PLC : FY 2025 Earnings & Q1 2026 Revenue
Published on 04/30/2026 at 19:16, 3 days ago

AXA announces the results of its Shareholders' Meeting
Published on 04/30/2026 at 19:00, 3 days ago

Capital increase through exercise of subscription rights
Published on 04/30/2026 at 18:10, 3 days 1 hour ago

Minutes of the Combined General Meeting held on April 30, 2026
Published on 04/30/2026 at 18:00, 3 days 1 hour ago

TF1 Q1 2026 results - Press release

View all LES ECHOS COMFI WIRE

News